早期整合姑息治疗对肺癌和胃肠道癌症患者的影响:一项随机临床试验
该随机临床试验将新诊断的不可治愈肺癌或非结直肠胃肠道癌症患者随机分为早期整合姑息治疗联合肿瘤治疗组(n=175)和常规治疗组(n=175)。结果显示,干预组在24周时生活质量改善更明显(1.59 vs -3.40;P=0.010),抑郁评分更低(调整后均值差-1.17;95%CI -2.33至-0.01;P=0.048),且临终时更可能与肿瘤医生讨论意愿(30.2% vs 14.5%;P=0.004),但12周生活质量无显著差异(0.39 vs -1.13;P=0.339)。
要点
- 早期整合姑息治疗在24周改善生活质量,12周未达显著差异。
- 干预组24周抑郁评分更低(调整后均值差-1.17;95%CI -2.33至-0.01)。
- 肺癌患者获益于生活质量和抑郁改善,胃肠道癌症两组均改善。
核心结论
- 对于新诊断的不可治愈癌症患者,早期整合姑息治疗改善了生活质量和其它显著结局,且效应因癌症类型而异。
- 早期整合姑息治疗可能如果针对各患者群体的特定需求则最为有效。
研究设计与样本
- 随机临床试验,2011年5月至2015年7月,纳入新诊断的不可治愈肺癌或非结直肠胃肠道癌症患者,随机分为早期整合姑息治疗联合肿瘤治疗组(n=175)和常规治疗组(n=175)。
- 干预组患者至少每月与姑息治疗临床医生会面一次直至死亡,常规治疗组患者按请求咨询姑息治疗临床医生。
主要发现
- 干预组相比常规治疗组,基线至24周生活质量改善更大(1.59 vs -3.40;P=0.010),但12周无显著差异(0.39 vs -1.13;P=0.339)。
- 干预组24周抑郁评分更低,控制基线评分后调整后均值差-1.17(95%CI -2.33至-0.01;P=0.048)。
- 干预效应因癌症类型而异:肺癌干预组在12周和24周报告生活质量和抑郁改善,而肺癌常规治疗组报告恶化;胃肠道癌症两组在12周均报告生活质量和情绪改善。
- 干预组相比常规治疗组,临终时更可能与肿瘤医生讨论意愿(30.2% vs 14.5%;P=0.004)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose We evaluated the impact of early integrated palliative care (PC) in patients with newly diagnosed lung and GI cancer. Patients and Methods We randomly assigned patients with newly diagnosed incurable lung or noncolorectal GI cancer to receive either early integrated PC and oncology care (n = 175) or usual care (n = 175) between May 2011 and July 2015. Patients who were assigned to the intervention met with a PC clinician at least once per month until death, whereas those who received usual care consulted a PC clinician upon request. The primary end point was change in quality of life (QOL) from baseline to week 12, per scoring by the Functional Assessment of Cancer Therapy-General scale. Secondary end points included change in QOL from baseline to week 24, change in depression per the Patient Health Questionnaire-9, and differences in end-of-life communication. Results Intervention patients ( v usual care) reported greater improvement in QOL from baseline to week 24 (1.59 v -3.40; P = .010) but not week 12 (0.39 v -1.13; P = .339). Intervention patients also reported lower depression at week 24, controlling for baseline scores (adjusted mean difference, -1.17; 95% CI, -2.33 to -0.01; P = .048). Intervention effects varied by cancer type, such that intervention patients with lung cancer reported improvements in QOL and depression at 12 and 24 weeks, whereas usual care patients with lung cancer reported deterioration. Patients with GI cancers in both study groups reported improvements in QOL and mood by week 12. Intervention patients versus usual care patients were more likely to discuss their wishes with their oncologist if they were dying (30.2% v 14.5%; P = .004). Conclusion For patients with newly diagnosed incurable cancers, early integrated PC improved QOL and other salient outcomes, with differential effects by cancer type. Early integrated PC may be most effective if targeted to the specific needs of each patient population.
引用
- Temel JS, Greer JA, El-Jawahri A, et al. Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial. J Clin Oncol. 2016. PMID: 28029308. doi:10.1200/JCO.2016.70.5046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。